Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting a biochemical response

被引：0
|
作者：
Yasuharu Imai
Akinori Kasahara
Hideo Tanaka
Takeshi Okanoue
Naoki Hiramatsu
Hirohito Tsubouchi
Kentaro Yoshioka
Sumio Kawata
Eiji Tanaka
Keisuke Hino
Katsuhiro Hayashi
Shinji Tamura
Yoshito Itoh
Yutaka Sasaki
Kendo Kiyosawa
Shinichi Kakumu
Kiwamu Okita
Norio Hayashi
机构：
[1] Ikeda Municipal Hospital,Department of Internal Medicine
[2] Osaka University Graduate School of Medicine,Department of General Medicine
[3] Osaka Medical Center for Cancer and Cardiovascular Diseases,Department of Cancer Control and Statistics
[4] Kyoto Prefectural University of Medicine,Molecular Gastroenterology and Hepatology
[5] Graduate School of Medical Science,Department of Molecular Therapeutics
[6] Osaka University Graduate School of Medicine,Second Department of Internal Medicine
[7] Miyazaki Medical College,Division of Gastroenterology, Department of Internal Medicine
[8] Nagoya University School of Medicine,Second Department of Medicine
[9] Yamagata University School of Medicine,Internal Medicine
[10] Shinshu University School of Medicine,Department of Gastroenterology and Hepatology
[11] ,Department of Internal Medicine and Molecular Science
[12] Yamaguchi University School of Medicine,Department of Gastroenterology and Hepatology, Graduate School of Medical Science
[13] Osaka University Graduate School of Medicine,Department of Internal Medicine, Division of Gastroenterology
[14] Kumamoto University,undefined
[15] Aichi Medical University School of Medicine,undefined
来源：
Journal of Gastroenterology | 2004年 / 39卷
关键词：
interferon; chronic hepatitis C; aged; liver-related mortality; standardized mortality ratio;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1069 / 1077
页数：8
相关论文
共 50 条
  • [1] Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting a biochemical response
    Imai, Y
    Kasahara, A
    Tanaka, H
    Okanoue, T
    Hiramatsu, N
    Tsubouchi, H
    Yoshioka, K
    Kawata, S
    Tanaka, E
    Hino, K
    Hayashi, K
    Tamura, S
    Itoh, Y
    Sasaki, Y
    Kiyosawa, K
    Kakumu, S
    Okita, K
    Hayashi, N
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (11) : 1069 - 1077
  • [2] Efficacy of interferon therapy for aged patients with chronic hepatitis C
    Yasuji Arase
    Hiromitsu Kumada
    Journal of Gastroenterology, 2004, 39 : 1123 - 1124
  • [3] Biochemical and virological response to interferon therapy in patients with chronic hepatitis C, co-infected with hepatitis G virus
    Shibahara, N
    Moriyama, M
    Abe, K
    Tanaka, N
    Arakawa, Y
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (01) : 43 - 50
  • [4] Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy
    Yasuji Arase
    Kenji Ikeda
    Akihito Tsubota
    Yoshiyuki Suzuki
    Satoshi Saitoh
    Masahiro Kobayashi
    Fumitaka Suzuki
    Norio Akuta
    Takashi Someya
    Tetsuya Hosaka
    Mariko Kobayashi
    Hiromitsu Kumada
    Journal of Gastroenterology, 2004, 39 : 455 - 460
  • [5] Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy
    Arase, Y
    Ikeda, K
    Tsubota, A
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Suzuki, F
    Akuta, N
    Someya, T
    Hosaka, T
    Kobayashi, M
    Kumada, H
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (05) : 455 - 460
  • [6] Efficacy of interferon therapy in elderly patients with chronic hepatitis C
    Koyama, R
    Arase, Y
    Ikeda, K
    Suzuki, F
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Akuta, N
    Someya, T
    Hosaka, T
    Sezaki, H
    Kobayashi, M
    Kumada, H
    INTERVIROLOGY, 2006, 49 (03) : 121 - 126
  • [7] Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death
    Kasahara, A
    Tanaka, H
    Okanoue, T
    Imai, Y
    Tsubouchi, H
    Yoshioka, K
    Kawata, S
    Tanaka, E
    Hino, K
    Hayashi, K
    Tamura, S
    Itoh, Y
    Kiyosawa, K
    Kakumu, S
    Okita, K
    Hayashi, N
    JOURNAL OF VIRAL HEPATITIS, 2004, 11 (02) : 148 - 156
  • [8] Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
    Hiramatsu, Naoki
    Oze, Tsugiko
    Tsuda, Natsuko
    Kurashige, Nao
    Koga, Keisuke
    Toyama, Takashi
    Yasumaru, Masakazu
    Kanto, Tatsuya
    Takehara, Tetsuo
    Kasahara, Akinori
    Kato, Michio
    Yoshihara, Harumasa
    Katayama, Kazuhiro
    Hijioka, Taizo
    Hagiwara, Hideki
    Kubota, Shinji
    Oshita, Masahide
    Haruna, Yoshimichi
    Mita, Eiji
    Suzuki, Kunio
    Ishibashi, Kazunobu
    Hayashi, Norio
    HEPATOLOGY RESEARCH, 2006, 35 (03) : 185 - 189
  • [9] Transient biochemical response in interferon therapy decreases the development of hepatocellular carcinoma for five years and improves the long-term survival of chronic hepatitis C patients
    Okanoue, T
    Itoh, Y
    Kirishima, T
    Daimon, Y
    Toyama, T
    Morita, A
    Nakajima, T
    Minami, M
    HEPATOLOGY RESEARCH, 2002, 23 (01) : 62 - 77
  • [10] Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C
    Takagi, H
    Nagamine, T
    Abe, T
    Takayama, H
    Sato, K
    Otsuka, T
    Kakizaki, S
    Hashimoto, Y
    Matsumoto, T
    Kojima, A
    Takezawa, J
    Suzuki, K
    Sato, S
    Mori, M
    JOURNAL OF VIRAL HEPATITIS, 2001, 8 (05) : 367 - 371
12345